These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8106293)

  • 21. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation.
    Sun X; Yang Z; Li S; Tan Y; Zhang N; Wang X; Yagi S; Yoshioka T; Takimoto A; Mitsushima K; Suginaka A; Frenkel EP; Hoffman RM
    Cancer Res; 2003 Dec; 63(23):8377-83. PubMed ID: 14678999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genetically modified recombinant tumor necrosis factor-alpha conjugated to the distal terminals of liposomal surface grafted polyethyleneglycol chains.
    Savva M; Duda E; Huang L
    Int J Pharm; 1999 Jul; 184(1):45-51. PubMed ID: 10425350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of TNF-alpha pharmacokinetics in SA-1 tumor-bearing mice.
    Kus B; Sersa G; Novaković S; Urbancic J; Stalc A
    Int J Cancer; 1993 Aug; 55(1):110-4. PubMed ID: 8344743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of PVP as a polymeric carrier to improve the plasma half-life of drugs.
    Kaneda Y; Tsutsumi Y; Yoshioka Y; Kamada H; Yamamoto Y; Kodaira H; Tsunoda S; Okamoto T; Mukai Y; Shibata H; Nakagawa S; Mayumi T
    Biomaterials; 2004 Jul; 25(16):3259-66. PubMed ID: 14980420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
    Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
    Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity.
    Yamamoto Y; Tsutsumi Y; Yoshioka Y; Nishibata T; Kobayashi K; Okamoto T; Mukai Y; Shimizu T; Nakagawa S; Nagata S; Mayumi T
    Nat Biotechnol; 2003 May; 21(5):546-52. PubMed ID: 12665803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PEGylation alleviates the non-specific toxicities of Alpha-Momorcharin and preserves its antitumor efficacy in vivo.
    Deng NH; Wang L; He QC; Zheng JC; Meng Y; Meng YF; Zhang CJ; Shen FB
    Drug Deliv; 2016; 23(1):95-100. PubMed ID: 24786488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5'-phosphate.
    Yang Z; Sun X; Li S; Tan Y; Wang X; Zhang N; Yagi S; Takakura T; Kobayashi Y; Takimoto A; Yoshioka T; Suginaka A; Frenkel EP; Hoffman RM
    Cancer Res; 2004 Aug; 64(16):5775-8. PubMed ID: 15313919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
    Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
    Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects.
    Nieforth KA; Nadeau R; Patel IH; Mould D
    Clin Pharmacol Ther; 1996 Jun; 59(6):636-46. PubMed ID: 8681488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model.
    Katre NV; Knauf MJ; Laird WJ
    Proc Natl Acad Sci U S A; 1987 Mar; 84(6):1487-91. PubMed ID: 3494243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced antitumor effect of recombinant human tumor necrosis factor in combination with recombinant human granulocyte colony-stimulating factor in BALB/c mice.
    Maeda M; Watanabe N; Tsuji N; Tsuji Y; Okamoto T; Sasaki H; Akiyama S; Niitsu Y
    Jpn J Cancer Res; 1993 Aug; 84(8):921-7. PubMed ID: 7691787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and properties of sterically stabilized hexadecylphosphocholine (miltefosine)-liposomes and influence of this modification on macrophage activation.
    Zeisig R; Eue I; Kosch M; Fichtner I; Arndt D
    Biochim Biophys Acta; 1996 Sep; 1283(2):177-84. PubMed ID: 8809097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting of tumor necrosis factor to tumor by use of dextran and metal coordination.
    Tabata Y; Noda Y; Matsui Y; Ikada Y
    J Control Release; 1999 May; 59(2):187-96. PubMed ID: 10332053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyethylene glycol (PEG)-modified granulocyte-macrophage colony-stimulating factor (GM-CSF) with conserved biological activity.
    Malik F; Delgado C; Knüsli C; Irvine AE; Fisher D; Francis GE
    Exp Hematol; 1992 Sep; 20(8):1028-35. PubMed ID: 1505637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective enhancement by tumor necrosis factor-alpha of vascular permeability of new blood vessels induced with agarose hydrogel-entrapped Meth-A fibrosarcoma cells.
    Okada N; Kaneda Y; Miyamoto H; Yamamoto Y; Mizuguchi H; Tsutsumi Y; Nakagawa S; Mayumi T
    Jpn J Cancer Res; 1996 Aug; 87(8):831-6. PubMed ID: 8797889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins.
    Richter AW; Akerblom E
    Int Arch Allergy Appl Immunol; 1983; 70(2):124-31. PubMed ID: 6401699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRINT: A Protein Bioconjugation Method with Exquisite N-terminal Specificity.
    Sur S; Qiao Y; Fries A; O'Meally RN; Cole RN; Kinzler KW; Vogelstein B; Zhou S
    Sci Rep; 2015 Dec; 5():18363. PubMed ID: 26678960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
    Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
    J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol.
    Hershfield MS; Chaffee S; Koro-Johnson L; Mary A; Smith AA; Short SA
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7185-9. PubMed ID: 1714590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.